{"id":"https://openalex.org/W1978956528","doi":"https://doi.org/10.1002/1097-0142(19810515)47:10<2414::aid-cncr2820471016>3.0.co;2-w","title":"Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: A safe new effective regimen","display_name":"Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: A safe new effective regimen","publication_year":1981,"publication_date":"1981-05-15","ids":{"openalex":"https://openalex.org/W1978956528","doi":"https://doi.org/10.1002/1097-0142(19810515)47:10<2414::aid-cncr2820471016>3.0.co;2-w","mag":"1978956528","pmid":"https://pubmed.ncbi.nlm.nih.gov/6974039"},"language":"en","primary_location":{"id":"doi:10.1002/1097-0142(19810515)47:10<2414::aid-cncr2820471016>3.0.co;2-w","doi":"https://doi.org/10.1002/1097-0142(19810515)47:10<2414::aid-cncr2820471016>3.0.co;2-w","is_oa":false,"landing_page_url":"https://doi.org/10.1002/1097-0142(19810515)47:10<2414::aid-cncr2820471016>3.0.co;2-w","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007239425","display_name":"John M. Kirkwood","orcid":"https://orcid.org/0000-0002-3570-4476","observed_orcids":["https://orcid.org/0000-0002-3570-4476"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John M. Kirkwood","raw_affiliation_strings":["The Section of Medical Oncology, Department Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Section of Medical Oncology, Department Internal Medicine, Yale University School of Medicine, New Haven, Connecticut","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110165931","display_name":"George P. Canellos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George P. Canellos","raw_affiliation_strings":["Division of Medical Oncology Sidney Farber Cancer Institute and The Joint Center for Radiation Therapy, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology Sidney Farber Cancer Institute and The Joint Center for Radiation Therapy, Boston, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055209325","display_name":"Thomas J. Ervin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas J. Ervin","raw_affiliation_strings":["Division of Medical Oncology Sidney Farber Cancer Institute and The Joint Center for Radiation Therapy, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology Sidney Farber Cancer Institute and The Joint Center for Radiation Therapy, Boston, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018775536","display_name":"Susan W. Pitman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan W. Pitman","raw_affiliation_strings":["The Section of Medical Oncology, Department Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Section of Medical Oncology, Department Internal Medicine, Yale University School of Medicine, New Haven, Connecticut","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111967581","display_name":"Ralph W. Weichselbaum","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ralph Weichselbaum","raw_affiliation_strings":["Division of Medical Oncology Sidney Farber Cancer Institute and The Joint Center for Radiation Therapy, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology Sidney Farber Cancer Institute and The Joint Center for Radiation Therapy, Boston, Massachusetts","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066718151","display_name":"Daniel Miller","orcid":"https://orcid.org/0000-0002-4697-1131","observed_orcids":["https://orcid.org/0000-0002-4697-1131"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Miller","raw_affiliation_strings":["Division of Medical Oncology Sidney Farber Cancer Institute and The Joint Center for Radiation Therapy, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology Sidney Farber Cancer Institute and The Joint Center for Radiation Therapy, Boston, Massachusetts","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5007239425"],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":8.7102,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.98051576,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"47","issue":"10","first_page":"2414","last_page":"2421"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11669","display_name":"Head and Neck Surgical Oncology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.921999990940094},{"id":"https://openalex.org/keywords/leucovorin","display_name":"leucovorin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9520000219345093},{"id":"https://openalex.org/keywords/twice-weekly-dosing","display_name":"twice-weekly dosing","score":0.7639999985694885},{"id":"https://openalex.org/keywords/high-dose-methotrexate","display_name":"high-dose methotrexate","score":0.8370000123977661},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.8119999766349792},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.9089999794960022},{"id":"https://openalex.org/keywords/gastrointestinal-toxicity","display_name":"gastrointestinal toxicity","score":0.9129999876022339},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8259999752044678},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.5260000228881836},{"id":"https://openalex.org/keywords/treatment-regimen-comparison","display_name":"treatment regimen comparison","score":0.4009999930858612}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.913256049156189},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.8227691650390625},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.8196724057197571},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6195346713066101},{"id":"https://openalex.org/C126189478","wikidata":"https://www.wikidata.org/wiki/Q1468324","display_name":"Nephrotoxicity","level":3,"score":0.5267854332923889},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.5191761255264282},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48165595531463623},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.46546268463134766},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.43942195177078247},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4352051913738251},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3640367388725281},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.22264450788497925},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.10885360836982727}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005767","descriptor_name":"Gastrointestinal Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009196","descriptor_name":"Myeloproliferative Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/1097-0142(19810515)47:10<2414::aid-cncr2820471016>3.0.co;2-w","doi":"https://doi.org/10.1002/1097-0142(19810515)47:10<2414::aid-cncr2820471016>3.0.co;2-w","is_oa":false,"landing_page_url":"https://doi.org/10.1002/1097-0142(19810515)47:10<2414::aid-cncr2820471016>3.0.co;2-w","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:6974039","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6974039","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.800000011920929,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W624430683","https://openalex.org/W1580714689","https://openalex.org/W1891954621","https://openalex.org/W1970494175","https://openalex.org/W1985850151","https://openalex.org/W1993867622","https://openalex.org/W1996101068","https://openalex.org/W2007067586","https://openalex.org/W2009052265","https://openalex.org/W2025660627","https://openalex.org/W2055400330","https://openalex.org/W2082863696","https://openalex.org/W2087251177","https://openalex.org/W2605580194","https://openalex.org/W4234155909","https://openalex.org/W4236896588"],"related_works":["https://openalex.org/W2409932570","https://openalex.org/W2026961013","https://openalex.org/W1926198890","https://openalex.org/W2252501309","https://openalex.org/W2408392821","https://openalex.org/W171738341","https://openalex.org/W1891954621","https://openalex.org/W2082284579","https://openalex.org/W1580714689","https://openalex.org/W335409112"],"abstract_inverted_index":{"A":[0],"new":[1,64],"intensive":[2,105,171],"methotrexate":[3,25,116,131],"regimen":[4,47,85],"for":[5,153],"the":[6,13,63,82,91,104,118,154,167],"treatment":[7],"of":[8,12,24,31,51,62,100,111,123,130,142,170],"advanced":[9],"squamous":[10],"carcinoma":[11],"head":[14],"and":[15,26,38,68,86,109,147,166],"neck":[16],"is":[17],"presented,":[18],"employing":[19],"twice-weekly":[20],"parenteral":[21,29],"low-moderate":[22,106,128,146],"doses":[23,129,135],"a":[27],"single":[28],"dose":[30,84,107,156,173],"leucovorin":[32],"24":[33],"hours":[34],"following":[35],"methotrexate.":[36],"Toxicity":[37],"therapeutic":[39],"results":[40,50],"in":[41,55,98,137],"20":[42],"patients":[43,57,101,112,125],"treated":[44,58,102],"with":[45,49,81,90,115,145,175],"this":[46,138],"favorably":[48],"weekly":[52,119],"high-dose":[53,92,120,148],"methotrexate-leucovorin":[54],"36":[56],"immediately":[59],"before":[60],"initiation":[61],"regimen.":[65,93],"Moderate":[66],"nephrotoxicity":[67],"mild":[69],"gastrointestinal/mucosal":[70],"toxicity":[71,169],"were":[72,150],"common":[73],"to":[74,133,158],"both,":[75],"while":[76],"myelotoxicity":[77],"was":[78,87,96],"rarely":[79],"seen":[80],"low":[83],"more":[88],"frequent":[89],"Partial":[94],"response":[95,144,160],"observed":[97],"60%":[99],"on":[103,117],"schedule,":[108],"50%":[110],"previously":[113,126],"untreated":[114],"schedule.":[121],"None":[122],"12":[124],"failing":[127],"responded":[132],"high":[134],"administered":[136],"trial.":[139],"The":[140],"characteristics":[141],"antitumor":[143],"schedules":[149],"similar":[151],"except":[152],"median":[155],"required":[157],"attain":[159],"(50":[161],"mg/m2":[162],"vs.":[163],"3":[164],"g/m2)":[165],"lesser":[168],"lower":[172],"therapy":[174],"leucovorin.":[176]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}